Detalles de la búsqueda
1.
High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen.
Eur Respir J
; 52(6)2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30361246
2.
Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis?
Eur Respir J
; 56(1)2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32471936
3.
Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study.
Lancet Infect Dis
; 22(7): 1042-1051, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35512718
4.
Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study.
Lancet Infect Dis
; 22(4): 496-506, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-34780706
5.
Compassionate use of new drugs in children and adolescents with multidrug-resistant and extensively drug-resistant tuberculosis: early experiences and challenges.
Eur Respir J
; 48(3): 938-43, 2016 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-27338197
6.
Sputum culture and drug sensitivity testing outcome among X-pert Mycobacterium tuberculosis/rifampicin-positive, rifampicin-resistant sputum: A retrospective study - Not all rifampicin resistance is multi-drug resistant.
J Glob Antimicrob Resist
; 21: 434-438, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31733411
7.
Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study.
Lancet Respir Med
; 6(9): 699-706, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30001994
Resultados
1 -
7
de 7
1
Próxima >
>>